Microsoft stock has demonstrated resilience in late 2025, maintaining a 16% year-to-date gain to close at $425.80 on December 24, despite a swirl of scepticism surrounding its aggressive artificial intelligence investments and deepening ties with OpenAI. The latest catalyst a
As digital transformation accelerates with AI tools reshaping 70 percent of business processes, reverse mentoring has emerged as a powerful bridge between generations. This model flips traditional hierarchies, pairing seasoned executives with younger talent to exchange knowledge, particularly in digital
Reverse Mentoring 2025: How Gen Z is Teaching C-Suite Digital Fluency at Deloitte Read More »
Novo Nordisk A/S (NYSE: NVO) shares rocketed more than 9% in premarket trading on December 23, 2025, extending gains after the U.S. Food and Drug Administration approved an oral version of the company’s blockbuster Wegovy obesity treatment, marking the first-ever
Rocket Lab USA Inc. (NASDAQ: RKLB), the innovative aerospace firm pioneering small satellite launches, has captured investor attention with a dramatic stock surge in late December 2025, climbing nearly 10% to close at $77.55 on December 22 following the successful
Permira, the London-based private equity giant, has agreed to sell a majority stake in Golden Goose, the iconic Italian luxury sneaker brand, to HSG Group, a Hong Kong-headquartered Chinese investment firm, in a transaction valued at approximately €1.3 billion. The
Medtronic plc (NYSE: MDT), the global medical device leader, took a significant step toward unlocking value in its high-growth diabetes segment on December 19, 2025, when its MiniMed Group subsidiary confidentially filed a registration statement with the U.S. Securities and
Nike shares plummeted more than 10% in premarket trading on December 19, 2025, extending losses after the sportswear behemoth reported fiscal second-quarter 2026 results that beat revenue and earnings expectations but revealed persistent challenges in China and escalating tariff pressures.
Nike Shares Plunge 10% After Q2 Earnings Beat on China Weakness and Tariff Fears Read More »
BioMarin Pharmaceutical (BMRN) announced on December 19, 2025, that it has entered into a definitive agreement to acquire Amicus Therapeutics Inc. (NASDAQ: FOLD) in an all-cash transaction valued at approximately $4.8 billion, creating a formidable powerhouse in the rare disease
As the gig economy evolves with AI-driven matching and regulatory reforms, the story of Uber’s transformation under CEO Dara Khosrowshahi remains a masterclass in crisis leadership. Appointed in 2017 amid scandals that nearly sank the $70 billion ride-hailing giant, Khosrowshahi
From Layoff Storm to Turnaround: Uber’s Dara Khosrowshahi on Rebuilding Trust in 2025 Read More »
United Parcel Service Inc. (NYSE: UPS) shares rose 1.1% on December 17, 2025, closing at $100.96, buoyed by the U.S. Postal Service’s announcement to reopen its last-mile delivery network to a broader array of shippers, a move poised to inject
